Pharma Journalist 8887 posts 0 comments

The 2025 summit offers an in-depth look at the most innovative technologies and scientific strategies shaping the future of microbiome-based therapies. This includes advancements in…
Read More...

Global pharma major Lupin Limited (Lupin) announced that it has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP), for the commercialization of Tiotropium…
Read More...

Celltrion, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA (ustekinumab-stba), a biosimilar to STELARA (ustekinumab), in a…
Read More...

NextCure, Inc. has announced a strategic collaboration with Simcere Zaiming, an oncology-focused subsidiary of Simcere Pharmaceutical Group Ltd. The partnership centers on the…
Read More...

Teva Pharmaceutical Industries Ltd. and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that the companies, through their respective subsidiaries, have entered a strategic…
Read More...

Averoa announced that the European Commission (EC) has granted marketing authorization for XOANACYL. This follows the positive opinion issued in March by the committee for Medicinal…
Read More...

As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of liver failure – affecting more than 250 million people…
Read More...

SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, announced the close of a $135 million Series B…
Read More...

Capsida Biotherapeutics announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for CAP-003, its potential best-in-class…
Read More...

Novo Nordisk announced that it will advance subcutaneous and oral amycretin into phase 3 development in weight management based on completed clinical studies. The decision to advance…
Read More...